CARY STREET PARTNERS INVESTMENT ADVISORY LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1766904
RICHMOND, VA
Position in GILD
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$467,705
-$70,258 QoQ
Shares Held
3,702
-4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,402
of 2,266 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $10,872,180 across 13 Drug Manufacturers - General names. GILD ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,853 | $3,421,967 | |
| 2 | ABBV |
AbbVie Inc.
|
9,052 | $2,277,835 | |
| 3 | JNJ |
Johnson & Johnson
|
5,727 | $1,454,479 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,104 | $1,041,359 | |
| 5 | AMGN |
Amgen Inc
|
2,175 | $787,606 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
3,702 | $467,705 | |
| 7 | NVS |
Novartis AG
|
2,406 | $377,067 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,072 | $349,863 |
All Filings in GILD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $467,705 | 3,702 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $537,963 | 3,860 | Shares | Other | 2026-04-29 | |
| 2025-12-31 | $476,594 | 3,883 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $456,987 | 4,117 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $393,806 | 3,552 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $349,480 | 3,119 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $256,138 | 2,773 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $584,276 | 6,969 | Shares | Other | 2024-10-30 | |
| 2024-06-30 | $478,826 | 6,979 | Shares | Other | 2024-07-22 | |
| 2024-03-31 | $463,597 | 6,329 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $511,413 | 6,313 | Shares | Other | 2024-02-07 | |
| 2023-09-30 | $321,416 | 4,289 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $188,590 | 2,447 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $198,879 | 2,397 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $212,221 | 2,472 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $173,904 | 2,819 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $167,010 | 2,702 | Shares | Sole | 2022-08-15 | |
| 2020-12-31 | $272,948 | 4,685 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $130,676 | 2,068 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||